— Know what they know.
Not Investment Advice
Also trades as: JNJ.DE (XETRA) · $vol 1M · JNJ.SW (SIX)

JNJ NYSE

Johnson & Johnson
1W: +6.4% 1M: +4.7% 3M: +18.4% YTD: +29.3% 1Y: +60.7% 3Y: +69.2% 5Y: +80.2%
$266.73
+0.78 (+0.29%)
 
Weekly Expected Move ±4.4%
$240 $252 $263 $275 $286
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Buy · Power 71 · $642.8B mcap · 2.41B float · 0.360% daily turnover · Short 61% of daily vol
Smart Money Score
Moderate 50
Insider
Congress4 trades
ETF Holdings
Key Statistics
Market Cap$642.8B
52W Range164.23-274.89
Volume10,390,341
Avg Volume8,665,953
Beta0.23
Dividend$5.24
Analyst Ratings
21 Buy 16 Hold 3 Sell
Consensus Buy
Company Info
CEOJoaquin Duato
Employees141,700
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1962-01-02
Websitejnj.com
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
US
732 524 0400
About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Recent Insider Trades

NameTypeSharesPriceDate
Broadhurst Vanessa M-Exempt 11,129 $129.51 2026-07-20
Broadhurst Vanessa M-Exempt 11,925 $131.94 2026-07-20
Broadhurst Vanessa S-Sale 23,054 $251.27 2026-07-20
Broadhurst Vanessa M-Exempt 11,129 $129.51 2026-07-20
Broadhurst Vanessa M-Exempt 11,925 $131.94 2026-07-20

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms